about
Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an updateThe establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes.Functional interference clusters in cancer patients with bone metastases: a secondary analysis of RTOG 9714.Sleep quality after initial chemotherapy for breast cancer.Predictors of the intensity of symptoms in a cluster in patients with breast cancer.ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trialsEfficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy.Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes.Subgroups of cancer patients with unique pain and fatigue experiences during chemotherapy.The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: a multi-center randomized trialRisk for unplanned hospital readmission of patients with cancer: results of a retrospective medical record review.The concept of symptom cluster.The elusive concept of the symptom cluster.Comparison of groups with different patterns of symptom cluster intensity across the breast cancer treatment trajectory.Recommendations for high-priority research on cancer-related fatigue in children and adults.Patients' experiences with cancer-related fatigue: a review and synthesis of qualitative research.Common biological pathways underlying the psychoneurological symptom cluster in cancer patients.Cancer-related fatigue and its impact on functioning.Recovery after transverse rectus abdominis myocutaneous flap breast reconstruction surgery.Management of cancer-related fatigue during chemotherapy through telephone motivational interviewing: modeling and randomized exploratory trial.Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy.Treatment-related symptom clusters in breast cancer: a secondary analysis.Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients.Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study.Communication between patients with breast cancer and health care providers. Determinants and implicationsPatient resources for cancer-related fatigueA randomized clinical trial of energy conservation for patients with cancer-related fatigueCancer-related fatigue, depressive symptoms, and functional status: a mediation modelStrategies for maintaining integrity of a behavioral interventionManagement of cancer-related fatigueSymptom cluster research: conceptual, design, measurement, and analysis issuesCancer symptom cluster research: new perspectives and toolsEvaluation of a Technology-Based Survivor Care Plan for Breast Cancer Survivors: Pre-Post Pilot Study
P50
Q28654636-6E433067-22D4-45CA-A997-2EC76DFF75CCQ33666335-8A19FB39-9891-4E9D-ABD2-14023F9F68F3Q33756061-C8E0D003-6441-4B26-8685-C4DED34F9B53Q33869481-81A7C793-268F-4A43-BF53-096087350C46Q33908488-5EA7FF78-5B1E-4686-82F6-734BA53EA40BQ34019470-EA0287D7-204F-449D-9BC8-F32DF3E6463EQ34065391-D55CC353-FF18-476C-8FD0-71A2AA9E2DBAQ34293847-E02A427B-048C-40F6-9562-634D6220F33FQ35532101-29EC2FD8-24F5-4352-8116-E22B045E324BQ35949039-42A89E73-9F15-4446-B0AC-80A510AAD509Q36468910-4B5E82C1-3A79-4F23-8C67-B17B52CC2CD3Q36826367-6130B9C3-BCEC-42D2-85F5-FC93987F3F54Q36945289-5F9580C9-B0E9-484C-A7DF-79A73C055B0DQ37014749-8DFA6AB8-43CA-434F-BC61-AEF1B3B9E8EBQ37463262-9015C0FE-848D-4426-9A0C-FE21FE3C9E78Q37870577-2B4F5249-2042-4C56-8D79-79E61ED63878Q37974146-726C9539-AEA4-45AD-AADE-4501ABB7D155Q38108549-4334443C-77D8-4B85-8751-89F3B0C9A8BDQ39322773-38FDB178-34D2-4E1E-AF3E-CF1F297D96C0Q41734322-AA31FE5A-EEFD-48B5-9898-1B114FE37ED0Q44866896-CD000E57-C61E-4EC4-A5C7-6E2C15299538Q46771675-22B9839B-4EEE-4579-AF0A-E97C4E01E8BEQ48592626-BB84E17A-ECFC-46C2-83F7-B225A9359A02Q53223364-7B895AB4-7AB8-41F1-A008-FA6D8AC313A8Q70487175-D6DC0248-4732-464F-A747-C3E28AC8B5E3Q77730351-7E3BE452-C757-4A10-8D14-BA8C37104323Q79778258-84E6A42E-B50E-4129-8B9A-99A8EB5A1A6DQ80277593-EAE141EA-CBB8-481E-AEE1-0D54CFF9EBB8Q81553900-95731836-C5A4-496E-B536-DEB2D57DFAD1Q82240086-FBBB30E4-749A-4C7F-8440-1F6EF72400B8Q82405449-56761366-6B4C-4544-AC0D-CFDAED2EAB7EQ85892667-387617BF-6FD5-4B4A-817C-9DF59C783632Q92145276-82BEC31D-8674-4AA8-8C0C-9DE456E4DAD4
P50
description
researcher ORCID ID = 0000-0003-1829-6826
@en
wetenschapper
@nl
name
Andrea Barsevick
@ast
Andrea Barsevick
@en
Andrea Barsevick
@es
Andrea Barsevick
@nl
type
label
Andrea Barsevick
@ast
Andrea Barsevick
@en
Andrea Barsevick
@es
Andrea Barsevick
@nl
prefLabel
Andrea Barsevick
@ast
Andrea Barsevick
@en
Andrea Barsevick
@es
Andrea Barsevick
@nl
P106
P1153
6701629091
P31
P496
0000-0003-1829-6826